FIELD: medicine.
SUBSTANCE: group of inventions refers to molecular biology, immunology and medicine and aims at identifying populations of autologous responding T-cells in the individuals suffering autoimmune diseases. Sampling the autoimmune T-cells in the individual suffering autoimmune diseases is ensured by producing a peptoid, which specifically binds to the autoimmune T-cells. The above peptoid binds to a carrier. The sample taken from the above individual contacts the above peptoid bound to the carrier over a period of time sufficient to bind the autoimmune T-cells to the above peptoid bound to the carrier. The above carrier is then separated from the above sample. The other embodiments provide methods for destructing the autoimmune T-cells taken from the individuals suffering an autoimmune disease.
EFFECT: using the group of inventions provides the more effective identification of various autoimmune diseases and conducting the anti-population therapy.
50 cl, 15 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
COMPOSITIONS FOR TREATMENT OF DISSEMINATED SCLEROSIS | 2008 |
|
RU2492234C2 |
RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | 2018 |
|
RU2790447C2 |
METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE | 2019 |
|
RU2814083C2 |
RELEASE AND IDENTIFICATION OF T-CELLS | 2003 |
|
RU2327487C2 |
IMMUNOTHERAPY METHODS | 2017 |
|
RU2756276C2 |
T-CELLULAR VACCINE FOR CEREBROSPINAL SCLEROSIS TREATMENT | 1998 |
|
RU2209633C2 |
METHOD FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERE | 2011 |
|
RU2635537C2 |
METHOD OF TREATING AUTOIMMUNE DISEASE (VERSIONS) | 2009 |
|
RU2539110C2 |
Authors
Dates
2015-09-20—Published
2010-05-28—Filed